Clinical Trial Update: Extended-Release Buprenorphine vs. Sublingual Buprenorphine for the Treatment of Opioid Use Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial comparing extended-release buprenorphine with sublingual buprenorphine for opioid use disorder is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Extended-Release Buprenorphine (buprenorphine extended-release formulation)
• Sublingual Buprenorphine (buprenorphine)

Snippet

Sponsor: Frances R Levin | Conditions: Opioid-use Disorder | Phase 2 | Status: SUSPENDED